RecruitingNot ApplicableNCT05494658

Impact of Preoperative Oral Branched-chain Amino Acids on Reducing Postoperative Insulin Resistance.

A Multicenter Randomized Controlled Study of Preoperative Oral Administration of Branched-chain Amino Acids in Reducing Postoperative Insulin Resistance in Colorectal Cancer Patients


Sponsor

Sun Peng

Enrollment

224 participants

Start Date

Aug 26, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Postoperative insulin resistance refers to the phenomenon that the body's glucose uptake stimulated by insulin is reduced due to stress effects such as trauma or the inhibitory effect of insulin on liver glucose output is weakened after surgery. There is a clear link between postoperative insulin resistance and poor perioperative prognosis. Therefore, exploring interventions to reduce postoperative stress insulin resistance, stabilize postoperative blood glucose, and reduce postoperative complications are clinical problems that need to be solved urgently. In recent years, research on branched-chain amino acids and metabolic diseases has become a hot spot. Studies have found that in the rat model, preoperatively given a high branched-chain amino acid diet can inhibit postoperative insulin resistance and stabilize blood glucose levels. This research plan is to try to add branched-chain amino acids before surgery to observe the occurrence of postoperative insulin resistance in patients.


Eligibility

Min Age: 50 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether taking branched-chain amino acid (BCAA) supplements by mouth before colorectal cancer surgery can reduce insulin resistance (a temporary blood sugar problem that often follows surgery). Better blood sugar control after surgery is associated with faster recovery and fewer complications. **You may be eligible if...** - You are between 50 and 80 years old - You have been diagnosed with colorectal cancer - You are scheduled for elective (non-emergency) laparoscopic surgery to remove the cancer - You are in good health (ASA score I–III) - You have given informed consent **You may NOT be eligible if...** - You have diabetes - You already have insulin resistance before surgery - You have serious kidney or liver disease - You have a bowel obstruction preventing normal eating - You are pregnant or breastfeeding - You have a severe mental illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTBCAA

600ml drink which contains 18g BCAA was consumed by patients 2-4h before surgery.

DIETARY_SUPPLEMENTwater

600ml water was consumed by patients 2-4h before suegery.


Locations(1)

Shanghai Tongren Hospital

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05494658


Related Trials